Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Motor Activity 126Breast Neoplasms 78Neoplasms 48Prostatic Neoplasms 19Fatigue 16Obesity 14Colorectal Neoplasms 13Lung Neoplasms 11Polycystic Ovary Syndrome 10Colonic Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Head and Neck Neoplasms 7Weight Loss 6Ovarian Neoplasms 6Rectal Neoplasms 5Multiple Myeloma 5Lymphedema 5Leukemia 5Inflammation 5Pancreatic Neoplasms 4Overweight 4Multiple Endocrine Neoplasia Type 1 4Lymphoma 4Leukemia, Myeloid, Acute 4Insulin Resistance 4Depression 4Cognitive Dysfunction 4Brain Neoplasms 4Stomach Neoplasms 3Peripheral Nervous System Diseases 3

Interventions

Standard of Care 1Hormones 1Exercise 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Anomia × Exercise × Clear all
NCT05894954 2026-02-18

EVANTHEA

Alzheimer's Prevention and Reversal Project, Inc.

Phase 3 Completed
73 enrolled
Lymphoid

Alzheimer Disease, Anomia, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡